NeuroDiscovery Begins Trials of NSL-101
NeuroDiscovery has started two Phase II clinical trials of NSL-101 in dental procedures.
The Peruvian, double-blind, randomized studies will evaluate the analgesic efficacy of NSL-101 in patients suffering pain after either the extraction of one or more wisdom teeth or scaling and root planing for periodontitis.
The analgesic efficacy of NSL-101 post-wisdom tooth extraction will be compared with placebo, and pain post scaling and root planing will be compared with the standard analgesic used in this procedure.
NeuroDiscovery said it anticipates the periodontitis trial will finish in the first quarter of 2008 and the wisdom tooth extraction trial will wrap up in the second quarter.